Logo image of MBI

MBIA INC (MBI) Stock Fundamental Analysis

NYSE:MBI - New York Stock Exchange, Inc. - US55262C1009 - Common Stock - Currency: USD

6.8  -0.11 (-1.59%)

After market: 6.8 0 (0%)

Fundamental Rating

1

Overall MBI gets a fundamental rating of 1 out of 10. We evaluated MBI against 144 industry peers in the Insurance industry. Both the profitability and financial health of MBI have multiple concerns. MBI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year MBI has reported negative net income.
MBI had a negative operating cash flow in the past year.
MBI had negative earnings in each of the past 5 years.
MBI had negative operating cash flow in 4 of the past 5 years.
MBI Yearly Net Income VS EBIT VS OCF VS FCFMBI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M -1B -1.5B

1.2 Ratios

The Return On Assets of MBI (-23.95%) is worse than 97.18% of its industry peers.
Industry RankSector Rank
ROA -23.95%
ROE N/A
ROIC N/A
ROA(3y)-11.44%
ROA(5y)-9.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MBI Yearly ROA, ROE, ROICMBI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 -200 -300

1.3 Margins

MBI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MBI Yearly Profit, Operating, Gross MarginsMBI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2K -4K -6K -8K

More info and screens

1

2. Health

2.1 Basic Checks

MBI has less shares outstanding than it did 1 year ago.
MBI has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, MBI has a worse debt to assets ratio.
MBI Yearly Shares OutstandingMBI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M
MBI Yearly Total Debt VS Total AssetsMBI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B

2.2 Solvency

Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
MBI Yearly LT Debt VS Equity VS FCFMBI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B 6B 8B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
MBI Yearly Current Assets VS Current LiabilitesMBI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

2

3. Growth

3.1 Past

MBI shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.24%.
Looking at the last year, MBI shows a very negative growth in Revenue. The Revenue has decreased by -128.72% in the last year.
Measured over the past years, MBI shows a very negative growth in Revenue. The Revenue has been decreasing by -48.40% on average per year.
EPS 1Y (TTM)3.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)-128.72%
Revenue growth 3Y-72.29%
Revenue growth 5Y-48.4%
Sales Q2Q%-10%

3.2 Future

The Earnings Per Share is expected to grow by 21.68% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -11.28% on average over the next years. This is quite bad
EPS Next Y28.22%
EPS Next 2Y33.1%
EPS Next 3Y21.68%
EPS Next 5YN/A
Revenue Next Year-11.11%
Revenue Next 2Y-14.55%
Revenue Next 3Y-11.28%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MBI Yearly Revenue VS EstimatesMBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
MBI Yearly EPS VS EstimatesMBI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 -4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

MBI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year MBI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MBI Price Earnings VS Forward Price EarningsMBI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MBI Per share dataMBI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -10 -20 -30

4.3 Compensation for Growth

A more expensive valuation may be justified as MBI's earnings are expected to grow with 21.68% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.1%
EPS Next 3Y21.68%

More info and screens

0

5. Dividend

5.1 Amount

MBI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MBIA INC

NYSE:MBI (2/21/2025, 8:04:00 PM)

After market: 6.8 0 (0%)

6.8

-0.11 (-1.59%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-27 2025-02-27/amc
Inst Owners49.83%
Inst Owner Change-97.07%
Ins Owners11.34%
Ins Owner Change-0.19%
Market Cap347.00M
Analysts74.29
Price Target6.89 (1.32%)
Short Float %3.91%
Short Ratio4.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend7.73
Dividend Growth(5Y)97.69%
DP-76.59%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-857.1%
Min EPS beat(2)-1814.19%
Max EPS beat(2)100%
EPS beat(4)1
Avg EPS beat(4)-492.85%
Min EPS beat(4)-1814.19%
Max EPS beat(4)100%
EPS beat(8)3
Avg EPS beat(8)-476.32%
EPS beat(12)4
Avg EPS beat(12)-374.31%
EPS beat(16)5
Avg EPS beat(16)-307.77%
Revenue beat(2)2
Avg Revenue beat(2)20.23%
Min Revenue beat(2)13.15%
Max Revenue beat(2)27.3%
Revenue beat(4)4
Avg Revenue beat(4)23.76%
Min Revenue beat(4)13.15%
Max Revenue beat(4)27.3%
Revenue beat(8)8
Avg Revenue beat(8)124.53%
Revenue beat(12)12
Avg Revenue beat(12)145.78%
Revenue beat(16)15
Avg Revenue beat(16)198.93%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-12.95%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.7%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.58
EYN/A
EPS(NY)-0.81
Fwd EYN/A
FCF(TTM)-3.55
FCFYN/A
OCF(TTM)-3.55
OCFYN/A
SpS-0.53
BVpS-38.96
TBVpS-38.96
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.95%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-11.44%
ROA(5y)-9.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover-0.01
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y28.22%
EPS Next 2Y33.1%
EPS Next 3Y21.68%
EPS Next 5YN/A
Revenue 1Y (TTM)-128.72%
Revenue growth 3Y-72.29%
Revenue growth 5Y-48.4%
Sales Q2Q%-10%
Revenue Next Year-11.11%
Revenue Next 2Y-14.55%
Revenue Next 3Y-11.28%
Revenue Next 5YN/A
EBIT growth 1Y-120.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-162.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-161.99%
OCF growth 3YN/A
OCF growth 5YN/A